248 related articles for article (PubMed ID: 21203485)
1. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1.
Kvansakul M; Wei AH; Fletcher JI; Willis SN; Chen L; Roberts AW; Huang DC; Colman PM
PLoS Pathog; 2010 Dec; 6(12):e1001236. PubMed ID: 21203485
[TBL] [Abstract][Full Text] [Related]
2. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.
Fitzsimmons L; Cartlidge R; Chang C; Sejic N; Galbraith LCA; Suraweera CD; Croom-Carter D; Dewson G; Tierney RJ; Bell AI; Shannon-Lowe C; Herold MJ; Rickinson AB; Colman PM; Huang DCS; Strasser A; Kvansakul M; Rowe M; Kelly GL
Cell Death Differ; 2020 May; 27(5):1554-1568. PubMed ID: 31645677
[TBL] [Abstract][Full Text] [Related]
3. Crystal Structures of Epstein-Barr Virus Bcl-2 Homolog BHRF1 Bound to Bid and Puma BH3 Motif Peptides.
Suraweera CD; Hinds MG; Kvansakul M
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298777
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim.
Desbien AL; Kappler JW; Marrack P
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5663-8. PubMed ID: 19293378
[TBL] [Abstract][Full Text] [Related]
5. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
Kelly GL; Long HM; Stylianou J; Thomas WA; Leese A; Bell AI; Bornkamm GW; Mautner J; Rickinson AB; Rowe M
PLoS Pathog; 2009 Mar; 5(3):e1000341. PubMed ID: 19283066
[TBL] [Abstract][Full Text] [Related]
6. Crystallization and preliminary X-ray characterization of Epstein-Barr virus BHRF1 in complex with a benzoylurea peptidomimetic.
Caria S; Chugh S; Nhu D; Lessene G; Kvansakul M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Dec; 68(Pt 12):1521-4. PubMed ID: 23192038
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
[TBL] [Abstract][Full Text] [Related]
8. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
[TBL] [Abstract][Full Text] [Related]
9. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2.
Huang Q; Petros AM; Virgin HW; Fesik SW; Olejniczak ET
J Mol Biol; 2003 Oct; 332(5):1123-30. PubMed ID: 14499614
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
[TBL] [Abstract][Full Text] [Related]
12. Herpesvirus pan encodes a functional homologue of BHRF1, the Epstein-Barr virus v-Bcl-2.
Howell M; Williams T; Hazlewood SA
BMC Microbiol; 2005 Feb; 5():6. PubMed ID: 15691372
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells.
Kawanishi M; Tada-Oikawa S; Kawanishi S
Biochem Biophys Res Commun; 2002 Sep; 297(3):682-7. PubMed ID: 12270148
[TBL] [Abstract][Full Text] [Related]
15. The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction.
Li LY; Shih HM; Liu MY; Chen JY
J Biol Chem; 2001 Jul; 276(29):27354-62. PubMed ID: 11373297
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.
Henderson S; Huen D; Rowe M; Dawson C; Johnson G; Rickinson A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8479-83. PubMed ID: 8397406
[TBL] [Abstract][Full Text] [Related]
17. The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.
Coghill AE; Proietti C; Liu Z; Krause L; Bethony J; Prokunina-Olsson L; Obajemu A; Nkrumah F; Biggar RJ; Bhatia K; Hildesheim A; Doolan DL; Mbulaiteye SM
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):57-62. PubMed ID: 31619404
[TBL] [Abstract][Full Text] [Related]
18. Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells.
Dawson CW; Dawson J; Jones R; Ward K; Young LS
J Virol; 1998 Nov; 72(11):9016-24. PubMed ID: 9765446
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
[TBL] [Abstract][Full Text] [Related]
20. Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.
Fitzsimmons L; Boyce AJ; Wei W; Chang C; Croom-Carter D; Tierney RJ; Herold MJ; Bell AI; Strasser A; Kelly GL; Rowe M
Cell Death Differ; 2018 Feb; 25(2):241-254. PubMed ID: 28960205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
